We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RAD Radiopharm Theranostics Limited

0.002 (6.67%)
14 Jun 2024 - Closed
Delayed by 20 minutes

Radiopharm Theranostics Financial Summary

The current RAD market cap is 14.06M. The company's latest EPS is AUD -0.0788 and P/E is -0.38.

Year End 30 June 2023 202120222023
Total Revenue 09k6.21M
Operating Income -484k-19.92M-33.81M
Net Income -485k-30.42M-34.61M
Year End 30 June 2023 202120222023
Total Assets 33k83.38M74.95M
Total Liabilities 158k20.42M29.37M
Total Equity -125k62.96M45.58M

Cash Flow

Year End 30 June 2023 202120222023
Operating -33k-9.91M-23.2M
Investing N/A -28.38M-1.53M
Financing 60k65.11M9.22M
Market Cap 14.06M
Price to Earnings Ratio -0.38
Price to Sales Ratio 2.13
Price to Cash Ratio 1.13
Price to Book Ratio 0.29
Dividend Yield -

Share Statistics

Shares Outstanding 439.36M
Average Volume (1 week) 1.03M
Average Volume (1 Month) 686.91k
52 Week Change -75.38%
52 Week High 0.155
52 Week Low 0.027
Spread (Intraday) 0 (9.09%)

Company Info

Company Name Radiopharm Theranostics Limited
Address level 3
melbourne, victoria 3053
Industry in vitro,in vivo diagnostics (2835)

Your Recent History

Delayed Upgrade Clock